More than a month after Johnson & Johnson announced that it will stop the sale of its talc-based baby powder globally in 2023, the Indian state of Maharashtra on Friday cancelled the manufacturing license of the pharmaceutical company.
Reportedly, the state's Food & Drug Administration (FDA) cancelled the company's license to manufacture the baby powder citing an inspection where it found its premier baby product to be sub-standard in quality.